Replies to post #4314 on Momenta Pharmaceuticals, Inc. (MNTA)

[EyeamBill]

I've Already Put Away A Celebratory Pint of Chivas

I hope you're right but I'm in no condition to argue otherwise (as if I'd want to).

I hope when I awake bright and early that it sounds like another good buying opp as it does now.

Bill

[EyeamBill]

Any Forex Experts Out There. . . ?

It seems that NVS, being European-based, reports earnings in Euros and then converts them to dollars. As my previous post will attest, I'm more inclined to take an interest this time of night in a bottle of Chivas in celebration than to endure the drudgery of actually listening to the call.

If this is true, then it would seem that the MNTA earnings would be influenced by currency trends.

If this has been addressed in a prior message then pardon me; Googling when you're already half-Googled full of Chivas is more than I can bear.

Or could it be that since m-Enox is only approved in the US that all earnings are reported by NVS in dollars?

Bill

[10nisman]

284 * .6816 (margin) * .45 (profit share) = 87.1 revenue
Assuming same expenses as last quarter = 21.1 gives us 66 mil profit. Using the same 50.45m shares used in the last quarter calculation (57.006 / 50.45 = $1.13) That would mean 66 / 50.45 = $1.31 earnings. Even if expenses increased to about 24 million, we would still have about 63 / 50.45 = $1.25
Does this seem right to you guys?

You need to include the annual mL true-up adjustment which was estimated to be $3-4 million. Based on the quarters strong sales, I would use $4 million as the adjustment to revenue so $83.1 million vs. $87.1 million. Earnings should fall between $1.18 and $1.30.

If the strong mL performance continues Momenta will be subject to paying Uncle Sam in Q4.